William D. Tap

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.836Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

Papers

Driven by 53 papers — median percentile 37. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4592

N/A

2.3DataRank · unranked

46 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

The Oncologist(2020)10.1002/onco.13629

N/A

1.9DataRank · unranked

61 citations

Hans Gelderblom, Michiel A. J. van de Sande, Silvia Stacchiotti, John H. Healey, William D. Tap +10 more

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

Annals of Oncology(2023)10.1016/j.annonc.2023.04.006

N/A

1.2DataRank · unranked

42 citations

Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski +13 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2007

N/A

0.965DataRank · unranked

32 citations

Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey +19 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232

N/A

0.749DataRank · unranked

146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009472

Top 32%

0.618DataRank

Top 32%16 citations

James L. Chen, Austin C Goodrich, Brian A. Van Tine, Jordan D. Campbell, Allison L. Richards +9 more

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0832

N/A

0.494DataRank · unranked

26 citations

Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Lou Keohan +12 more

ATRX guards against aberrant differentiation in mesenchymal progenitor cells

Nucleic Acids Research(2024)10.1093/nar/gkae160

N/A

0.442DataRank · unranked

11 citations

Douglas Barrows, Yakshi Dabas, Thomas S. Carroll, S. J. Singer, William D. Tap +2 more

Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor

Journal of Gastrointestinal Surgery(2020)10.1007/s11605-020-04843-9

N/A

0.442DataRank · unranked

18 citations

Kenneth Seier, Mithat Gönen, Christina Curtin, Vinod P. Balachandran, William D. Tap +4 more

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Cancers(2022)10.3390/cancers14174334

N/A

0.269DataRank · unranked

5 citations

Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann +42 more

Undifferentiated Pleomorphic Sarcoma in Children and Young Adults: A Comprehensive Clinicopathologic, Genomic, and Epigenetic Comparison With Adult Counterparts

Modern Pathology(2025)10.1016/j.modpat.2025.100769

N/A

0.260DataRank · unranked

4 citations

Gunes Gundem, Chad Vanderbilt, Leonard H. Wexler, Damon R. Reed, William D. Tap +7 more

Characterizing TP53 mutations in bone and soft tissue sarcoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e23521

Top 63%

0.218DataRank

Top 63%2 citations

Ryan Q. Notti, William D. Tap, Olayode O. Babatunde

Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response

Modern Pathology(2023)10.1016/j.modpat.2023.100165

N/A

0DataRank · unranked

40 citations

Walid K. Chatila, Cecilia Lezcano, Christopher A. Febres‐Aldana, Nikolaus Schultz, Chad Vanderbilt +10 more

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2378

N/A

0DataRank · unranked

36 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

Cancer Research(2023)10.1158/0008-5472.can-23-0385

N/A

0DataRank · unranked

27 citations

Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold, Max F. Levine, Gunes Gundem +25 more

Stereotactic body radiation therapy for sarcoma pulmonary metastases

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109824

N/A

0DataRank · unranked

16 citations

Stephanie Lobaugh, Zhigang Zhang, Mark A. Dickson, Evan Rosenbaum, Sandra P. D’Angelo +12 more

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0140

N/A

0DataRank · unranked

11 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Incremental Utility of First-Pass Perfusion CMR for Prognostic Risk Stratification of Cancer-Associated Cardiac Masses

JACC. Cardiovascular imaging(2023)10.1016/j.jcmg.2023.05.007

N/A

0DataRank · unranked

7 citations

Tania Ruiz Maya, Christine Park, Katherine Tak, Nicole Liberman, Raina H. Jain +11 more

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11590

N/A

0DataRank · unranked

3 citations

Evan Rosenbaum, Rodrigo Gularte Mérida, Mark A. Dickson, Mary Louise Keohan, Mrinal M. Gounder +15 more

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.05.522765

N/A

0DataRank · unranked

1 citations

Simone Zaccaria, Alvin P. Makohon-Moore, Brian J. Arnold, Max F. Levine, Gunes Gundem +25 more

Data from Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial

(2023)10.1158/1078-0432.c.6530537

Top 100%

0DataRank

Top 100%0 citations

Andrew J. Wagner, Akira Kawai, Kazuo Tamura, Ashwin Shahir, Brian A. Van Tine +5 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242.v1

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy

Nature Cancer(2024)10.1038/s43018-024-00743-y

N/A

0DataRank · unranked

59 citations

Neda Nemat‐Gorgani, Timothy John Ellis-Caleo, David G.P. van IJzendoorn, Timothy J. Sears, Anish Somani +20 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

Nature Communications(2024)10.1038/s41467-024-49486-5

N/A

0DataRank · unranked

11 citations

Yakshi Dabas, Matthew R. Paul, Christian Pacheco, Michelle M. Mitchener, Yekaterina Perez +14 more

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy‐induced pathologic response in breast angiosarcoma

Genes Chromosomes and Cancer(2024)10.1002/gcc.23240

N/A

0DataRank · unranked

6 citations

Josephine K. Dermawan, M. Gabriela Kuba, Aimeé M. Crago, Samuel Singer, William D. Tap +5 more

DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation Sequencing

Head and Neck Pathology(2024)10.1007/s12105-024-01634-5

N/A

0DataRank · unranked

1 citations

Chuanyong Lu, Ivana Petrović, Khédoudja Nafa, Wen Chen, Aijazuddin Syed +9 more

Data from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

(2024)10.1158/1078-0432.c.7077823.v1

N/A

0DataRank · unranked

0 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapy

The Oncologist(2025)10.1093/oncolo/oyaf370

N/A

0DataRank · unranked

2 citations

Joseph S. Wallins, I‐Hsin Lin, Sujana Movva, William D. Tap, Jennifer E Liu +2 more

Deep-Learning Tool ScVital Enables Species-Agnostic Integration of Cancer Cell States

Cancer Research(2025)10.1158/0008-5472.can-24-4889

N/A

0DataRank · unranked

1 citations

Jason E. Chan, Carleigh Sussman, Gary Guzman, William D. Tap, Cristina R. Antonescu +4 more

Effect of Acupuncture and Massage on Pain in Adolescent and Young Adult Patients with Advanced Cancer: Subgroup Analysis of a Randomized Clinical Trial

Journal of Adolescent and Young Adult Oncology(2025)10.1177/21565333251368891

N/A

0DataRank · unranked

1 citations

Xiaotong Li, Qing S. Li, Raymond E. Baser, Katherine S. Panageas, Susan Chimonas +5 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockade

npj Precision Oncology(2025)10.1038/s41698-025-00878-w

N/A

0DataRank · unranked

2 citations

Sara Coca Membribes, Cristina Anthonescu, Martina Bradić, Bernard O’Malley, Irina Linkov +9 more

Secondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma

Genes Chromosomes and Cancer(2025)10.1002/gcc.70076

N/A

0DataRank · unranked

0 citations

Hsin‐Yi Chang, Carla Saoud, Josephine K. Dermawan, Meera Hameed, Samuel Singer +3 more

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3959

N/A

0DataRank · unranked

119 citations

Shweta S. Chavan, David B. Solit, Rajmohan Murali, Robert A. Soslow, Sarah Chiang +9 more

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Cancer(2020)10.1002/cncr.33312

N/A

0DataRank · unranked

70 citations

Andrew J. Wagner, William D. Tap, Emanuela Palmerini, Zev A. Wainberg, Jayesh Desai +11 more

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors

The Journal of Clinical Pharmacology(2020)10.1002/jcph.1753

N/A

0DataRank · unranked

12 citations

Andrew J. Wagner, Jia Kang, William Knebel, Hamim Zahir, Michiel A. J. van de Sande +6 more

A multicenter phase II study of nivolumab +/- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11511

N/A

0DataRank · unranked

50 citations

Michelle R. Mahoney, Suzanne George, Cristina R. Antonescu, David A. Liebner, Brian Andrew Van Tine +6 more

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11562

N/A

0DataRank · unranked

7 citations

Michelle R. Mahoney, Fabrizio Remotti, Ardaman Shergill, Mark A. Dickson, Richard F. Riedel +10 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618

N/A

0DataRank · unranked

229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

CPT Pharmacometrics & Systems Pharmacology(2021)10.1002/psp4.12712

N/A

0DataRank · unranked

10 citations

Hamim Zahir, Jonathan French, Daniel Polhamus, Xiaoning Wang, Michiel A. J. van de Sande +8 more

Imaging-based patient inclusion model for clinical trial performance optimization.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.105

N/A

0DataRank · unranked

0 citations

Shuxuan Fan, Qi Jin, Alberto López García, Youngchul Kim, Matthew B. Schabath +7 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004149

N/A

0DataRank · unranked

58 citations

Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards +17 more

Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study

Modern Pathology(2022)10.1038/s41379-022-01107-6

N/A

0DataRank · unranked

44 citations

Sinchun Hwang, Leonard H. Wexler, William D. Tap, Samuel Singer, Chad Vanderbilt +2 more

The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms

Modern Pathology(2022)10.1038/s41379-022-01148-x

N/A

0DataRank · unranked

29 citations

Samuel Singer, William D. Tap, Benjamin A. Nacev, Ping Chi, Leonard H. Wexler +4 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

William D. Tap

Indexed papers

Top data-sharing exemplar

Papers